Despite progress in treatment for inflammatory bowel disease, patients and providers reported differing expectations as to remission and other aspects of disease control in a recent global survey, as presented in a poster during the 2020 Congress of the European Crohn’s and Colitis Organisation.

“For me personally, it was really eye opening to see the differences from a physician perspective and the patient perspective on certain aspects,” Anita Afzali, MD, of The Ohio State University, told Healio Gastroenterology and Liver Disease. “There was a clear disconnect.”

Full Article: